The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome–dependent processing of IL-1β
Open accessAbstract
Interleukin 1 (IL-1) is an important mediator of innate immunity but can also promote inflammatory tissue damage. During chronic infections such as tuberculosis, the beneficial antimicrobial role of IL-1 must be balanced with the need to prevent immunopathology. By exogenously controlling the replication of Mycobacterium tuberculosis in vivo, we obviated the requirement for antimicrobial immunity and discovered that both IL-1 production and infection-induced immunopathology were suppressed by lymphocyte-derived interferon-γ (IFN-γ). This effect was mediated by nitric oxide (NO), which we found specifically inhibited assembly of the NLRP3 inflammasome via thiol nitrosylation. Our data indicate that the NO produced as a result of adaptive immunity is indispensable in modulating the destructive innate inflammatory responses elicited during persistent infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, NO directly blocks inflammasome activation via nitrosylation of NLRP3, thereby preventing excessive tissue damage in the course of M. tuberculosis infection (102, 103).”
From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [103]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Self-citationImmunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627
Self-citationNathan, C., & Ding, A. (2010) · Cell · doi:10.1016/j.cell.2010.02.029 · Cited by 2,183
Stamler (2001) · doi:10.1016/s0092-8674(01)00495-0 · Cited by 1,261
Identification of nitric oxide synthase as a protective locus against tuberculosis
MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., & Nathan, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5243 · Cited by 1,180
Franchi, L., Amer, A., Body-Malapel, M., Kanneganti, T.-D., Özören, N., Jagirdar, R., Inohara, N., Vandenabeele, P., Bertin, J., Coyle, A., et al. (2006) · Nature Immunology · doi:10.1038/ni1346 · Cited by 1,131
Fernandes-Alnemri, T., Wu, J., Yu, J.-W., Datta, P., Miller, B., Jankowski, W., Rosenberg, S., Zhang, J., & Alnemri, E. S. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402194 · Cited by 1,026
Regulation of inflammasome signaling
Rathinam, V. A. K., Vanaja, S. K., & Fitzgerald, K. A. (2012) · Nature Immunology · doi:10.1038/ni.2237 · Cited by 960
Self-citationThe Biotin Switch Method for the Detection of S -Nitrosylated Proteins
Jaffrey, S. R., & Snyder, S. H. (2001) · Science Signaling · doi:10.1126/stke.2001.86.pl1 · Cited by 855
Research works printed but not linked: 1
- Nandi, B. & Behar, S.M. Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection. J. Exp. Med. 208, 2251–2262 (2011). · DOI
Cited by
Sorted by citations
The NLRP3 Inflammasome: an overview of mechanisms of activation and regulation
Kelley, N., Jeltema, D., Duan, Y., & He, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133328 · Cited by 3,539
Inflammasomes: mechanism of assembly, regulation and signalling
Broz, P., & Dixit, V. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.58 · Cited by 3,500
Activation and regulation of the inflammasomes
Latz, E., Xiao, T. S., & Stutz, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3452 · Cited by 2,884
Reactive oxygen species and mitochondria: A nexus of cellular homeostasis
Dunn, J. D., Álvarez, L., Zhang, X., & Soldati, T. (2015) · Redox Biology · doi:10.1016/j.redox.2015.09.005 · Cited by 1,233
Regulation of inflammasome activation
Man, S. M., & Kanneganti, T. (2015) · Immunological Reviews · doi:10.1111/imr.12296 · Cited by 1,088
Inflammasome activation and regulation: toward a better understanding of complex mechanisms
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Discovery · doi:10.1038/s41421-020-0167-x · Cited by 1,078
Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome
Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., & Zhou, R. (2015) · Cell · doi:10.1016/j.cell.2014.11.047 · Cited by 1,014
Macrophage defense mechanisms against intracellular bacteria
Weiss, G., & Schaible, U. E. (2015) · Immunological Reviews · doi:10.1111/imr.12266 · Cited by 989
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Grebe, A., Hoss, F., & Latz, E. (2018) · Circulation Research · doi:10.1161/circresaha.118.311362 · Cited by 926
An update on the regulatory mechanisms of NLRP3 inflammasome activation
Paik, S., Kim, J. K., Silwal, P., Sasakawa, C., & Jo, E. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00670-3 · Cited by 943
Nitric oxide synthase in innate and adaptive immunity: an update
Bogdan, C. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.01.003 · Cited by 862
Yan, Y., Jiang, W., Spinetti, T., Tardivel, A., Castillo, R., Bourquin, C., Guarda, G., Tian, Z., Tschopp, J., & Zhou, R. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.015 · Cited by 784
Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasome
Afonina, I. S., Zhong, Z., Karin, M., & Beyaert, R. (2017) · Nature Immunology · doi:10.1038/ni.3772 · Cited by 785
Mechanism of NLRP3 inflammasome activation
Sutterwala, F. S., Haasken, S., & Cassel, S. L. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12458 · Cited by 736
Immune evasion and provocation by Mycobacterium tuberculosis
Chandra, P., Grigsby, S. J., & Philips, J. A. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00763-4 · Cited by 652
Interplay Between NLRP3 Inflammasome and Autophagy
Biasizzo, M., & Kopitar‐Jerala, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.591803 · Cited by 636
Redox regulation of immunometabolism
Muri, J., & Köpf, M. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00478-8 · Cited by 519
NLRP3 inflammasome in neurological diseases, from functions to therapies
Song, L., Pei, L., Yao, S., Wu, Y., & Shang, Y. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00063 · Cited by 467
Regulation of iNOS on Immune Cells and Its Role in Diseases
Xue, Q., Yan, Y., Zhang, R., & Xiong, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123805 · Cited by 421
Mechanisms of NOD-like Receptor-Associated Inflammasome Activation
Wen, H., Miao, E. A., & Ting, J. P. ‐. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.037 · Cited by 415
Sakai, S., Kauffman, K. D., Sallin, M. A., Sharpe, A. H., Young, H. A., Ganusov, V. V., & Barber, D. L. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005667 · Cited by 349
Mattila, J. T., Ojo, O. O., Kepka‐Lenhart, D., Marino, S., Kim, J. H., Eum, S. Y., Via, L. E., Barry, C. E., Klein, E. C., Kirschner, D. E., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300113 · Cited by 340
Wang, F., Zhang, S., Jeon, R., Vuckovic, I., Jiang, X., Lerman, A., Folmes, C. D., Dzeja, P. D., & Herrmann, J. (2018) · eBioMedicine · doi:10.1016/j.ebiom.2018.02.009 · Cited by 339
TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity
Kimura, T., Jain, A., Choi, S. W., Mandell, M. A., Schroder, K., Johansen, T., & Deretic, V. P. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201503023 · Cited by 331
NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain
Stutz, A., Kolbe, C., Stahl, R., Horvath, G. L., Franklin, B. S., van Ray, O., Brinkschulte, R., Geyer, M., Meissner, F., & Latz, E. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160933 · Cited by 338
In search of a new paradigm for protective immunity to TB
Nunes-Alves, C., Booty, M. G., Carpenter, S. M., Jayaraman, P., Rothchild, A. C., & Behar, S. M. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3230 · Cited by 320
Immunology of Mycobacterium tuberculosis Infections
Sia, J. K., & Rengarajan, J. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0022-2018 · Cited by 337
Mechanisms and pathways of innate immune activation and regulation in health and cancer
Cui, J., Chen, Y., Wang, H. Y., & Wang, R. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/21645515.2014.979640 · Cited by 327
The role of inflammasomes in kidney disease
Komada, T., & Muruve, D. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0158-z · Cited by 317
Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control
Próchnicki, T., & Latz, E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.018 · Cited by 302
NLRP3 at the interface of metabolism and inflammation
Haneklaus, M., & O'Neill, L. A. J. (2015) · Immunological Reviews · doi:10.1111/imr.12285 · Cited by 296
Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis
Mishra, B. B., Lovewell, R. R., Olive, A. J., Zhang, G., Wang, W., Eugenín, E. A., Smith, C. M., Phuah, J. Y., Long, J. E., Dubuke, M. L., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.72 · Cited by 285
Self-citationToward targeting inflammasomes: insights into their regulation and activation
Christgen, S. L., Place, D. E., & Kanneganti, T. (2020) · Cell Research · doi:10.1038/s41422-020-0295-8 · Cited by 290
The Role of Interferons in Inflammation and Inflammasome Activation
Kopitar-Jerala, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00873 · Cited by 260
The regulation of inflammation by interferons and their STATs
Rauch, I., Müller, M. M., & Decker, T. (2013) · JAK-STAT · doi:10.4161/jkst.23820 · Cited by 292
Gideon, H. P., Hughes, T. K., Tzouanas, C. N., Wadsworth, M. H., Tu, A. A., Gierahn, T. M., Peters, J. M., Hopkins, F. F., Wei, J.-R., Kummerlowe, C., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.004 · Cited by 282
Contribution of metabolic reprogramming to macrophage plasticity and function
Kasmi, K. C. E., & Stenmark, K. R. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.09.001 · Cited by 281
Bailey, J. D., Diotallevi, M., NICOL, T., McNeill, E., Shaw, A., Chuaiphichai, S., Hale, A., Starr, A., Nandi, M., Stylianou, E., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.018 · Cited by 266
Nitric Oxide: A Key Mediator of Biofilm Dispersal with Applications in Infectious Diseases
Barraud, N., Kelso, M. J., Rice, S., & Kjelleberg, S. J. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140905112822 · Cited by 263
The balance between protective and pathogenic immune responses in the TB-infected lung
Orme, I. M., Robinson, R., & Cooper, A. M. (2014) · Nature Immunology · doi:10.1038/ni.3048 · Cited by 295
Kumar, M., Sahu, S. K., Kumar, R., Subuddhi, A., Maji, R. K., Jana, K., Gupta, P., Raffetseder, J., Lerm, M., Ghosh, Z., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.01.007 · Cited by 259
Lu, F., Lan, Z., Xin, Z., He, C., Guo, Z., Xia, X., & Hu, T. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29268 · Cited by 248
Itaconate confers tolerance to late NLRP3 inflammasome activation
Bambousková, M., Potůčková, L., Paulenda, T., Kerndl, M., Mogilenko, D. A., Lizotte, K., Swain, A., Hayes, S., Sheldon, R. D., Kim, H., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108756 · Cited by 247
Kieler, M., Hofmann, M., & Schabbauer, G. (2021) · FEBS Journal · doi:10.1111/febs.15715 · Cited by 250
The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases
de Torre‐Minguela, C., Mesa-del-Castillo, P., & Pelegrín, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00043 · Cited by 251
Choline Uptake and Metabolism Modulate Macrophage IL-1β and IL-18 Production
Sánchez‐López, E., Zhong, Z., Stubelius, A., Sweeney, S., Booshehri, L. M., Antonucci, L., Liu‐Bryan, R., Lodi, A., Terkeltaub, R. A., Lacal, J. C., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.03.011 · Cited by 240
Nitric Oxide in Macrophage Immunometabolism: Hiding in Plain Sight
Palmieri, E. M., McGinity, C., Wink, D. A., & McVicar, D. W. (2020) · Metabolites · doi:10.3390/metabo10110429 · Cited by 237
NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma
McKee, C. M., & Coll, R. C. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0720-513r · Cited by 246
HIF-1α Is an Essential Mediator of IFN-γ–Dependent Immunity to Mycobacterium tuberculosis
Braverman, J., Sogi, K. M., Benjamin, D. I., Nomura, D. K., & Stanley, S. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600266 · Cited by 230
Knight, M., Braverman, J., Asfaha, K., Gronert, K., & Stanley, S. A. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006874 · Cited by 220
Mayer-Barber, K. D., & Yan, B. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.25 · Cited by 210
Pseudomonas aeruginosa in Chronic Lung Infections: How to Adapt Within the Host?
Faure, E., Kwong, K., & Nguyen, D. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02416 · Cited by 227
New Insights into Mechanisms Controlling the NLRP3 Inflammasome and Its Role in Lung Disease
Nardo, D. D., Nardo, C. M. D., & Latz, E. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.09.007 · Cited by 206
The Innate Immune Response to Mycobacterium tuberculosis Infection
Ravesloot-Chávez, M. M., Dis, E. S. V., & Stanley, S. A. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-010426 · Cited by 213
Post-translational regulation of inflammasomes
Yang, J., Liu, Z., & Xiao, T. S. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.29 · Cited by 211
NLRP3 inflammasome pathways in atherosclerosis
Baldrighi, M., Mallat, Z., & Li, X. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.10.027 · Cited by 204
McNab, F. W., Ewbank, J., Howes, A., Moreira-Teixeira, L., Մարտիրոսյան, Ա., Ghilardi, N., Saraiva, M., & O’Garra, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401088 · Cited by 211
Of inflammasomes and pathogens – sensing of microbes by the inflammasome
Bauernfeind, F. G., & Hornung, V. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201771 · Cited by 198
Molecular mechanisms of inflammasome signaling
Mathur, A., Hayward, J. A., & Man, S. M. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0617-250r · Cited by 192
Griess reaction-based paper strip for colorimetric/fluorescent/SERS triple sensing of nitrite
Li, D., Ma, Y., Duan, H., Deng, W., & Li, D. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.08.008 · Cited by 185
Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by IL-1Ra
Ji, D. X., Yamashiro, L. H., Chen, K. J., Mukaida, N., Kramnik, I., Darwin, K. H., & Vance, R. E. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0578-3 · Cited by 183
Tuberculosis and the art of macrophage manipulation
Upadhyay, S., Mittal, E., & Philips, J. A. (2018) · Pathogens and Disease · doi:10.1093/femspd/fty037 · Cited by 186
Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders
Zhou, K., Shi, L., Wang, Y., Chen, S., & Zhang, J. (2016) · Journal of Immunology Research · doi:10.1155/2016/9238290 · Cited by 175
The cytoskeleton in cell-autonomous immunity: structural determinants of host defence
Mostowy, S., & Shenoy, A. R. (2015) · Nature reviews. Immunology · doi:10.1038/nri3877 · Cited by 190
Qi, M., Ren, X., Li, W., Sun, Y. L., Sun, X., Li, C., Yu, S., Xu, L. H., Zhou, Y., Song, S., et al. (2021) · Nano Today · doi:10.1016/j.nantod.2022.101447 · Cited by 175
Pyroptosis is a critical immune-inflammatory response involved in atherosclerosis
He, X., Fan, X., Bai, B., Lu, N., Zhang, S., & Zhang, L. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105447 · Cited by 174
The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors
Virgilio, F. D. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006171 · Cited by 168
Mouton‐Liger, F., Rosazza, T., Sepulveda‐Diaz, J., Ieang, A., Hassoun, S., Claire, E., Mangone, G., Brice, A., Michel, P. P., Corvol, J., et al. (2018) · Glia · doi:10.1002/glia.23337 · Cited by 160
Histones trigger sterile inflammation by activating the NLRP 3 inflammasome
Allam, R., Darisipudi, M. N., Tschopp, J., & Anders, H. (2013) · European Journal of Immunology · doi:10.1002/eji.201243224 · Cited by 163
Cytokine and lipid mediator networks in tuberculosis
Mayer-Barber, K. D., & Sher, A. (2015) · Immunological Reviews · doi:10.1111/imr.12249 · Cited by 158
Inflammasomes: Threat-Assessment Organelles of the Innate Immune System
Evavold, C. L., & Kagan, J. C. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.005 · Cited by 159
The Signaling Pathways Regulating NLRP3 Inflammasome Activation
Chen, M.-Y., Ye, X.-J., He, X.-H., & Ouyang, D.-Y. (2021) · Inflammation · doi:10.1007/s10753-021-01439-6 · Cited by 154
MRI-guided and ultrasound-triggered release of NO by advanced nanomedicine
Jin, Z., Wen, Y., Hu, Y., Chen, W., Zheng, X., Guo, W., Wang, T., Qian, Z., Su, B., & He, Q. (2017) · Nanoscale · doi:10.1039/c7nr00231a · Cited by 153
Cadena, A. M., Flynn, J. L., & Fortune, S. M. (2016) · mBio · doi:10.1128/mbio.00342-16 · Cited by 153
Mycobacterial Dormancy Systems and Host Responses in Tuberculosis
Peddireddy, V., Doddam, S. N., & Ahmed, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00084 · Cited by 157
How Inflammasomes Inform Adaptive Immunity
Evavold, C. L., & Kagan, J. C. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.09.019 · Cited by 155
Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis
Dorhoi, A., & Kaufmann, S. H. E. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0531-3 · Cited by 156
Wang, R., Wang, Y., Mu, N., Lou, X., Li, W., Chen, Y., Dong, F., & Tan, H. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.30 · Cited by 144
Braverman, J., & Stanley, S. A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700515 · Cited by 140
Sex differences in tuberculosis
Hertz, D., & Schneider, B. E. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0725-6 · Cited by 152
NLRP3 inflammasome in ischemic stroke: As possible therapeutic target
Alishahi, M., Farzaneh, M., Ghaedrahmati, F., Nejabatdoust, A., Sarkaki, A., & Khoshnam, S. E. (2019) · International Journal of Stroke · doi:10.1177/1747493019841242 · Cited by 144
Hoyt, L. R., Randall, M. J., Ather, J. L., DePuccio, D. P., Landry, C. C., Qian, X., Janssen-Heininger, Y. M. W., van der Vliet, A., Dixon, A. E., Amiel, E., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.020 · Cited by 142
Inflammation in tuberculosis: interactions, imbalances and interventions
Kaufmann, S. H. E., & Dorhoi, A. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.05.005 · Cited by 138
Natural Compounds as Regulators of NLRP3 Inflammasome-Mediated IL-1 β Production
Tőzsér, J., & Benkő, S. (2016) · Mediators of Inflammation · doi:10.1155/2016/5460302 · Cited by 129
Unsolved Mysteries in NLR Biology
Lupfer, C. R., & Kanneganti, T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00285 · Cited by 130
McClean, C. M., & Tobin, D. M. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw068 · Cited by 135
NLRP3 Inflammasome and Host Protection against Bacterial Infection
Kim, J.-J., & Jo, E. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.10.1415 · Cited by 124
Zhang, Q., Sun, J., Wang, Y., He, W., Wang, L., Zheng, Y., Wu, J., Zhang, Y., & Jiang, X. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02142 · Cited by 124
Optical/electrochemical methods for detecting mitochondrial energy metabolism
Ji, W., Tang, X. X., Du, W., Lu, Y., Wang, N., Wu, Q., Wei, W., Liu, J., Yu, H., Ma, B., et al. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01610a · Cited by 124
Oxidants, Antioxidants and Thiol Redox Switches in the Control of Regulated Cell Death Pathways
Benhar, M. (2020) · Antioxidants · doi:10.3390/antiox9040309 · Cited by 122
Inflammation and tuberculosis: host‐directed therapies
Zumla, A. I., Rao, M., Parida, S. K., Keshavjee, S. A., Cassell, G. H., Wallis, R. S., Axelsson‐Robertson, R., Doherty, M. T., Andersson, J., & Maeurer, M. J. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12256 · Cited by 120
Zhang, G., Zhou, B., Li, S., Yue, J., Yang, H., Wen, Y., Zhan, S., Wang, W., Liao, M., Zhang, M., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004426 · Cited by 121
Self-citationAmaral, E. P., Riteau, N., Moayeri, M., Maier, N. K., Mayer-Barber, K. D., Pereira, R. M., Lage, S. L., Kübler, A., Bishai, W. R., Lima, M. R. D., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01427 · Cited by 118
Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis
Jamaati, H., Mortaz, E., Pajouhi, Z., Folkerts, G., Movassaghi, M., Moloudizargari, M., Adcock, I. M., & Garssen, J. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02008 · Cited by 118
Donovan, M. L., Schultz, T. E., Duke, T. J., & Blumenthal, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01633 · Cited by 117
Host-pathogen genetic interactions underlie tuberculosis susceptibility in genetically diverse mice
Smith, C. M., Baker, R. E., Proulx, M. K., Mishra, B. B., Long, J. E., Park, S. W., Lee, H.-N., Kiritsy, M. C., Bellerose, M. M., Olive, A. J., et al. (2022) · eLife · doi:10.7554/elife.74419 · Cited by 126
Self-citationPrinciples of inflammasome priming and inhibition: implications for psychiatric disorders
Herman, F. J., & Pasinetti, G. M. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.06.010 · Cited by 115
Re-thinking the functions of IgA + plasma cells
Gommerman, J. L., Rojas, O. L., & Fritz, J. H. (2014) · Gut Microbes · doi:10.4161/19490976.2014.969977 · Cited by 117
Targeting NLRP3 Inflammasome Activation in Severe Asthma
Theofani, E., Semitekolou, M., Morianos, I., Samitas, Κ., & Xanthou, G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101615 · Cited by 122
Wang, X., Zhai, Y., Xu, L., Qiao, C., Sun, X., Ding, J., Lu, M., & Hu, G. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.11.001 · Cited by 112
Metadata
- Authors
- Mishra, B. B., Rathinam, V. A. K., Martens, G. W., Martinot, A. J., Kornfeld, H., Fitzgerald, K. A., & Sassetti, C. M.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Harvard University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Sassetti, Christopher M
- ORCID
- Venue
- Nature Immunology
- Published
- 2012-11-18
- Volume
- 14
- Issue
- 1
- Pages
- 52-60
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC3721324
- OpenAlex
- W2048884877
- Cited by
- 571
- References
- 49
- Citations by year
- 2026: 24 · 2025: 27 · 2024: 29 · 2023: 39 · 2022: 47 · 2021: 53 · 2020: 46 · 2019: 43 · 2018: 51 · 2017: 46 · 2016: 46 · 2015: 40 · 2014: 40 · 2013: 37 · 2012: 3
- FWCI
- 15.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Heart, Lung, and Blood Institute (R01HL064884, R01HL081149, HL064884)
- National Institute of Allergy and Infectious Diseases (AI064282, R01AI064282, AI083713, U54AI057159, R01AI083713, T32AI007638)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- nitric oxide, NLRP3 inflammasome, interleukin-1β processing, tuberculosis, immunopathology, Mycobacterium tuberculosis, nitrosylation, interferon-gamma, innate immunity, chronic infection, adaptive immunity
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Cells, Cultured, Humans, Immunity, Innate, Interferon-gamma, Mice, Inbred C57BL, Mycobacterium tuberculosis, Nitric Oxide, Tuberculosis, Signal Transduction, Mice, Knockout, Protein Modification, Translational, Mice, Interleukin-1beta, Protein Multimerization, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review